NCT05761431View on ClinicalTrials.gov

A Single-dose Study of Octreotide Injection in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

June 28, 2023

Study Completion Date

June 28, 2023

Conditions
Acromegaly
Interventions
DRUG

SYHX2008 injection

Subcutaneous administration on Day 1.

DRUG

Octreotide Acetate Microspheres for Injection injection

Intramuscular administration on Day 1.

DRUG

Sandostatin ® injection

Subcutaneous administration on Day 1.

DRUG

Placebo to SYHX2008 injection

Subcutaneous administration on Day 1.

Trial Locations (1)

100000

Beijing Anzhen Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY